Zoetis Inc.
As of Oct 23, 2026 close
- Market cap
- $33.85B
- P/E (TTM)
- 12.94
- Forward P/E
- 13.36
- Dividend yield
- 2.55%
- 52-week range
- $68.77$148.30
- Volume (live)
- -
- Avg. volume (3M)
- 4.14M
Zoetis (ZTS) Stock Price & Financial Analysis
Zoetis Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $80.60 - $81.86 |
|---|---|
| 52-Week High | $148.30 |
| 52-Week Low | $68.77 |
| Open | $81.14 |
| Volume (last close) | 2.86M |
| Average Volume (3M) | 4.14M |
| Revenue (TTM) | 9.52B |
|---|---|
| Net Income (TTM) | 2.62B |
| Free Cash Flow (TTM) | 2.37B |
| EPS (TTM) | $6.08 |
| Profit Margin | 27.49% |
| Operating Margin | 37.65% |
| Return on Equity (ROE) | 83.10% |
| Debt to Equity | 2.87 |
| Annual Dividend | $2.09 |
|---|---|
| Dividend Yield | 2.55% |
| Payout Ratio | 34.39% |
| Next Dividend Ex-Date | Oct 30, 2026 |
| Market Cap | 33.85B |
|---|---|
| Shares Outstanding | 417.70M |
| P/E Ratio (TTM) | 12.94 |
| Forward P/E | 13.36 |
| Price to Sales (P/S) | 3.56 |
| Price to Book (P/B) | 10.75 |
| EV/EBITDA | 10.28 |
| 50-Day MA | $74.23 |
|---|---|
| 200-Day MA | $95.41 |
| 1-Year Change | −43.99% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Zoetis at a Glance
As of the Oct 23, 2026 close, Zoetis (ZTS) has a market capitalization of $33.85B. The stock trades at 12.9× trailing earnings, 13.4× forward earnings and 3.6× sales. Over the trailing twelve months it earned $2.62B on revenue of $9.52B (a 27.5% profit margin) and generated $2.37B of free cash flow. Revenue grew 1.6% year over year.
As of its latest reported balance sheet, it holds $1.47B in cash and securities against $9.05B of debt, a net debt position of $7.58B.
Zoetis pays a quarterly dividend totaling $2.09 per share a year, a 2.55% yield at the Oct 23, 2026 close, with a 34% payout ratio and 12 consecutive years of dividend increases.
The share price is down 44.0% over the past year. At $81.03 (the Oct 23, 2026 close) it sits within its 52-week range of $68.77 to $148.30, below its 200-day moving average of $95.41.
Based on 13 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $88.63, 9.4% above the Oct 23, 2026 close.
Frequently Asked Questions About Zoetis
What is the current stock price for ZTS?
As of the Oct 23, 2026 close, ZTS stock trades at $81.03. The 52-week range is $68.77–$148.30, with a day range of $80.60–$81.86.
What is the P/E ratio for ZTS?
As of the Oct 23, 2026 close, Zoetis's trailing twelve-month (TTM) P/E ratio is 12.9, meaning investors pay $12.9 for every $1 of annual earnings. The forward P/E is 13.4, reflecting analyst expectations for future earnings. Zoetis operates in the Healthcare sector.
Does ZTS pay dividends?
Yes, Zoetis pays a 2.55% annual dividend yield as of the Oct 23, 2026 close ($2.09 per share a year). The trailing twelve-month payout ratio is 34.4%. The next ex-dividend date is October 30, 2026.
What do analysts recommend for ZTS?
Based on ratings from 13 professional analysts over the last 90 days, the consensus for ZTS is Hold. The average 12-month price target is $88.63, a 9.4% upside from the Oct 23, 2026 close of $81.03.
What is the market cap of ZTS?
As of the Oct 23, 2026 close, Zoetis's market capitalization is $33.85B, classifying it as a large-cap company. Zoetis operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.